Risk of CIN 3+ in HPV+ Women with Normal Cytology and 5 year Type Concordance (Publication)

A new publication of the RISCC consortium is published online ahead of print in Cancer Epidemiology, Biomarkers & Prevention. The study aims to demonstrate the potential of 5-year HPV type concordance as a disease marker for HPV-positive and cytology-negative women. First author is Federica Inturrisi. The full manuscript can be found here. A visual summary of the study can be found below.

lightbox

Direct effect of HPV vaccination on lifetime risk of precancer (Publication)

A new publication of the RISCC consortium was published this summer in the International Journal of Cancer. This research study conducted by Federica Inturrisi and colleagues aims to estimate the lifetime risk of (screen-detected) CIN2+ and CIN3+, using the using the Populationā€based Screening Study Amsterdam (POBASCAM). The full manuscript can be found here. A visual summary of the study can be found below.

Lightbox